Learning and research

A comprehensive library of abstracts, scientific talks, scientific papers, and research on pulmonary vascular disease

Reset filters
8 January 2025

Webinar presentations: Cardiopulmonary networks: bridging infection and microbiome in pulmonary vascular disease; Inflammasome activation in pulmonary arterial hypertension; Role of oxidative signals in endothelial phenotypes in PH; Spironolactone: an old drug with new tricks; HIPPO/MST signaling via BUB3 and FOXO drives pulmonary vascular cell growth and survival
 

Members Only
7 January 2025

Pulmonary hypertension (PH) affects patients at all stages of life, but there are important aspects that differentiate pediatric from adult disease. The pediatric task force at the 7th World Symposium on Pulmonary Hypertension (WSPH) recently highlighted our latest understanding of these differences, including considerations relating to PH definition, classification, treatment, and prognostication.

Pulmonary Circulation
24 December 2024

This study aimed to explore the potential causal link between genetic predisposition to various connective tissue diseases (CTDs), namely systemic lupus erythematosus (SLE), Sjögren's syndrome (SS), polymyositis (PM), dermatomyositis (DM), systemic sclerosis (SSc), mixed connective tissue disease (MCTD), and rheumatoid arthritis (RA), and the incidence of pulmonary arterial hypertension (PAH) utilizing Mendelian randomization (MR). 

Pulmonary Circulation
23 December 2024

The 7th International Leh Symposium on “Molecular Mechanisms and Therapeutics of Hypoxic Lung” from August 4 to 9, 2024, organized at the Mahabodhi International Meditation Centre in Saboo, Leh, Ladakh, India, ensured the participation of a galaxy of national and international researchers, who explored the complex clinico-physiological processes associated with high-altitude adaptive and maladaptive mechanisms.

Pulmonary Circulation